SCHEMBL7244684

SCHEMBL7244684

COc1cc(S(=O)(=O)C(F)(F)F)ccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
EPAS1 Q99814 3/20 0.49
RXFP1 Q9HBX9 2/20 0.46
KDM4E B2RXH2 4/20 0.45
HPGD P15428 2/20 0.44
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
USP2 O75604 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.42
AVPR2 P30518 1/20 0.42
GPR27 Q9NS67 1/20 0.42
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
FLT1 P17948 1/20 0.41
FLT4 P35916 1/20 0.41
KDR P35968 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34474839 1.00 ALDH1A1 (0.51) ALDH1A1EPAS1RXFP1KDM4EHPGD
SCHEMBL642859 0.81 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDPPARGPPARA
SCHEMBL28242926 0.81 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDPPARGPPARA
SCHEMBL751534 0.80 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDPPARGPPARA
SCHEMBL1050258 0.80 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDPPARGPPARA
SCHEMBL3198514 0.79 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDPPARGPPARA
SCHEMBL34475343 0.78 GPR27 (0.60) ALDH1A1RXFP1KDM4EHPGDKMT2A
SCHEMBL10669297 0.77 MAPT (0.60) ALDH1A1KDM4EHPGDPPARGPPARA
SCHEMBL11821095 0.76 EPAS1 (0.46) ALDH1A1EPAS1KDM4EHPGDMEN1
SCHEMBL5578273 0.76 ALDH1A1 (0.64) ALDH1A1EPAS1RXFP1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203941-A1 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus WYETH (US) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203941-A1 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus GPR119, INSR, SLC5A1 ALDH1A1 536/4885EPAS1 979/4885RXFP1 762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.